Not sure about that . Namely because in the first 4 days of trading since 26th May , we had 13,982,679 or 4.47% were exchanged on the ASX , with a further 23,998,407 or 7.67% of the total SOI of 312,776,182 and 36.62 % of Tranche 1. changing hands on the ASX in the following 5 days .So that's a total of 37,981,086 or 12.14% of the total SOI and 5.8% of Tranche 1 being turned over in just he 11 days of trading since 26th May 2020.So again if you then presume that the the additional 10% of Tranche 2 will go to a cornerstone , that would leave 42,518,352 under the ' refreshed 15% 7.1 capacity limit going to existing shareholders which would most likely look like something like a 1 for 7 entitlement rights issue.So in my book that's a potential dilution of anywhere between 70 - 80 % to existing shareholders across both Tranche 1 and Tranche 2. Especially when it comes off such a marginally held Top 20 and an overall lower comparative SOI than say others in the same sector.So in my opinion , this would go along way in explaining why there seems to be this ' underlying ' strong impetus and demand to increase holdings by a factor of 2 - 3 times the issue price. This and because Tolga has ' scooped ' up what looks to be only a starting position with his 7.36%.And we must keep in mind that this sort of ' dilution ' is significant given that many of the smaller shareholders would have obtained their existing at anywhere from a 30 - 40% discount to the issue price of this particular capital raise so may in fact be quite prepared to average up their current holdings ahead of their diluted allocation.y - if you base Tranche 2 on the ' refreshed 15% ' limit with the I would definitely
- Forums
- ASX - By Stock
- RGL
- Ann: CASH AND US$5M EARN-IN & JOINT VENTURE AGREEMENT FOR ALASKA
Ann: CASH AND US$5M EARN-IN & JOINT VENTURE AGREEMENT FOR ALASKA, page-36
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $8.467M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.7¢ | $259.8K | 34.17M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4299526 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 6686426 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 4299526 | 0.007 |
22 | 7999263 | 0.006 |
37 | 15681851 | 0.005 |
13 | 7299444 | 0.004 |
11 | 13946667 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 6686426 | 13 |
0.009 | 6945497 | 15 |
0.010 | 3739626 | 9 |
0.011 | 3192850 | 7 |
0.012 | 185635 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RGL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online